Evidence map›Paper›PMID 36553143›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Retinal and Visual Pathways Involvement in Carriers of Friedreich's Ataxia.

Lucia Ziccardi, Lucilla Barbano, Giulio Antonelli, Ettore Cioffi, Antonio Di Renzo, Valeria Gioiosa, Christian Marcotulli, Andrzej Grzybowski, Carlo Casali, Vincenzo Parisi

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Lucia ZiccardiIRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.ORCID 0000-0002-5563-1243
Lucilla BarbanoIRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.
Giulio AntonelliIRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.ORCID 0000-0002-5200-6071
Ettore CioffiDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9720-1065
Antonio Di RenzoIRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.
Valeria GioiosaDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.
Christian MarcotulliDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.
Andrzej GrzybowskiDepartment of Ophthalmology, University of Warmia and Mazury, Michała Oczapowskiego 2, 10455 Olsztyn, Poland.ORCID 0000-0002-3724-2391
Carlo CasaliDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy.
Vincenzo ParisiIRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy.
Fondazione G.B. Bietti · ITSapienza University of Rome · ITUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Friedreich’s ataxia (FRDA) is a rare autosomal recessive neurodegenerative disorder due to the homozygous pathological expansion of guanine-adenine-adenine (GAA) triplet repeats in the first intron of the FXN gene, which encodes for the mitochondrial protein frataxin. In the visual system, the typical manifestations are ocular motility abnormality, optic neuropathy, and retinopathy. Despite the evidence of ophthalmological impairment in FRDA patients, there is a lack of information about the morpho-functional condition of the retina and of the optic pathways in healthy heterozygous carriers of Friedreich’s ataxia (C-FRDA). Ten C-FRDA subjects (providing 20 eyes) and thirty-five Controls (providing 70 eyes) underwent a complete neurological and ophthalmological examination comprehensive of functional (full-field Electroretinogram (ffERG), multifocal Electroretinogram (mfERG), Visual Evoked Potential (VEP), and Pattern Reversal Electroretinogram (PERG)) and morphological assessments (Optical Coherence Tomography, OCT) of the retina, macula, retinal ganglion cells, and visual pathways. The groups’ data were compared using a two-sample t-test. Pearson’s test was used to investigate the morpho-functional correlations. Statistically significant differences (p < 0.01) between C-FRDA and Control eyes for the values of the following parameters were found: ffERG b-wave amplitude, mfERG Response Amplitude Densities, PERG P50 implicit time and P50-N95 amplitude, VEP P100 implicit time, Retinal Nerve Fiber Layer (RNFL) Overall, and Nasal thickness. The values of the OCT macular volume were not statistically different (p > 0.01) between the two Groups. Therefore, our data suggest that, in C-FRDA, a dysfunction of retinal elements without morphological macular impairment may occur. In addition, a morphological impairment of RNFL associated with an abnormal neural conduction along the visual pathways can be also detected.

Indexed as

ataxiacarriersERGFriedreichmfERGOCTPERGVEP

Identifiers

PMID36553143
PMCPMC9777201
OpenAlexW4311351193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.